West Pharmaceutical Services | WST - Cash And Equivalent


West Pharmaceutical Services reported $435.8M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Align Technology USD 1.1B 42.76M Jun/2026
Baxter International USD 2.15B 133M Jun/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Cerus USD 19.96M 4.29M Dec/2025
Charles River Laboratories USD 192.02M 195K Jun/2026
Cooper Companies USD 138.8M 13.9M Mar/2026
Dentsply International USD 239M 49M Jun/2026
Haemonetics USD 223.38M 22.06M Jun/2026
ICU Medical USD 288.33M 19.63M Mar/2026
Insulet USD 534.9M 54.5M Jun/2026
Integra LifeSciences USD 214.42M 22.39M Jun/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
J&J USD 20.42B 1.27B Jun/2026
Medtronic USD 1.69B 258M Jun/2026
Merit Medical Systems USD 448.7M 39.38M Jun/2026
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 160.58M 16.38M Jun/2026
Quidel USD 123.4M 17M Jun/2026
Repligen USD 606.78M 24.13M Jun/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
Solventum Corp USD 403M 158M Jun/2026
STAAR Surgical USD 148.58M 16.72M Jun/2026
Terumo JPY 280.49B 63.34B Mar/2026
Utah Medical Products USD 84.27M 2.09M Sep/2025
West Pharmaceutical Services USD 435.8M 85.6M Jun/2026